NRC's Q2 Earnings Rise Y/Y on Cost Control and TRCV Growth

National Research Corporation (NRC) reported a Q2 2025 GAAP net loss of $0.1 million, primarily due to $6.6 million in one-time executive compensation expenses, resulting in a 10% stock decline post-earnings and a 24.4% monthly drop, significantly underperforming the S&P 500. Despite the headline loss, adjusted net income rose to $6.4 million, and adjusted EBITDA remained stable at $10.3 million, reflecting underlying operational stability. Notably, Total Recurring Contract Value (TRCV) grew 2% sequentially, its strongest gain since early 2021, driven by improved sales and customer retention, while new CEO Trent Green expressed optimism and committed to enhanced transparency.

Analysis

National Research Corporation (NRC) experienced a significant negative market reaction, with its stock declining 10% post-earnings and 24.4% over the past month, driven by a reported Q2 GAAP net loss of $0.1 million. This loss, however, was almost entirely attributable to a $6.6 million non-recurring executive compensation expense related to a leadership transition. When excluding this one-time charge, the company's underlying financial health appears stable and shows signs of improvement. Adjusted net income rose to $6.4 million from $6.1 million year-over-year, and adjusted EPS increased to 28 cents from 26 cents. Furthermore, adjusted EBITDA was flat at $10.3 million, maintaining a strong margin of 30.3%, which indicates consistent core operational profitability. The most compelling positive indicator is the 2% sequential growth in Total Recurring Contract Value (TRCV), its strongest gain since early 2021, suggesting a potential acceleration in future revenue. This momentum is supported by management's commentary on a strengthened salesforce and improved customer retention. Despite these operational bright spots, the balance sheet shows increased leverage, with total debt rising to $81 million from $62.7 million, while shareholder equity declined, partly due to the company returning $16.1 million to shareholders year-to-date via dividends and buybacks.

Key Decisions for Investors

• Investors should look beyond the headline GAAP loss, which was distorted by a one-time charge, and focus on the growth in Total Recurring Contract Value (TRCV) as a key forward-looking indicator of revenue stabilization and growth.
• The significant increase in total debt to $81 million warrants close monitoring; continued capital returns should be weighed against the need to manage this higher leverage profile.
• The new CEO's reinstatement of earnings calls enhances transparency, and investors should use these calls to gauge management's ability to convert the recent TRCV momentum into tangible top-line growth in subsequent quarters.
• Given the stock's 24.4% monthly decline in contrast with improving underlying fundamentals, a potential valuation disconnect may exist for long-term investors who can tolerate the short-term noise from the leadership transition.